Literature DB >> 10556162

Inflammation and repair processes in chronic obstructive pulmonary disease.

S I Rennard1.   

Abstract

COPD is characterized by chronic inflammation and injury of both the airways and the parenchymal structures of the lung. These processes are associated with ongoing repair. Whether repair leads to restoration of normal tissue architecture or to altered tissue structure with loss of function depends on complex interrelationships of a variety of interacting mediators. The possibility that repair processes can be modulated by exogenous agents raises the possibility that therapeutic strategies aimed at repair can be effective. Such strategies offer tremendous promise both for slowing the relentlessly progressive natural history which most often characterizes COPD and, possibly, for restoring lung function. Rennard SI. Inflammation and repair processes in chronic obstructive pulmonary disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10556162     DOI: 10.1164/ajrccm.160.supplement_1.5

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  29 in total

1.  Dual function inhibitors of relevance to chronic obstructive pulmonary disease.

Authors:  Dengfeng Dou; Guijia He; Kevin R Alliston; William C Groutas
Journal:  Bioorg Med Chem Lett       Date:  2010-12-10       Impact factor: 2.823

2.  Effects of structure on inhibitory activity in a series of mechanism-based inhibitors of human neutrophil elastase.

Authors:  Dengfeng Dou; Guijia He; Rongze Kuang; Qingfong Fu; Radhika Venkataraman; William C Groutas
Journal:  Bioorg Med Chem       Date:  2010-08-05       Impact factor: 3.641

3.  Glucocorticoids and TGF-beta1 synergize in augmenting fibroblast mediated contraction of collagen gels.

Authors:  F Q Wen; C M Sköld; X D Liu; R F Ertl; Y K Zhu; T Kohyama; H Wang; S I Rennard
Journal:  Inflammation       Date:  2001-04       Impact factor: 4.092

4.  Overexpression of apoptotic cell removal receptor MERTK in alveolar macrophages of cigarette smokers.

Authors:  Angeliki Kazeros; Ben-Gary Harvey; Brendan J Carolan; Holly Vanni; Anja Krause; Ronald G Crystal
Journal:  Am J Respir Cell Mol Biol       Date:  2008-06-27       Impact factor: 6.914

5.  Comorbid conditions are associated with healthcare utilization, medical charges and mortality of patients with rheumatoid arthritis.

Authors:  Guang-Ming Han; Xiao-Feng Han
Journal:  Clin Rheumatol       Date:  2016-04-23       Impact factor: 2.980

6.  Reprogramming of COPD lung fibroblasts through formation of induced pluripotent stem cells.

Authors:  Hesham Basma; Yoko Gunji; Shunichiro Iwasawa; Amy Nelson; Maha Farid; Jun Ikari; Xiangde Liu; Xingqi Wang; Joel Michalski; Lynette Smith; Javeed Iqbal; Radwa El Behery; William West; Sowmya Yelamanchili; Deborah Rennard; Olaf Holz; Kai-Christian Mueller; Helgo Magnussen; Klaus Rabe; Peter J Castaldi; Stephen I Rennard
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-01-31       Impact factor: 5.464

7.  Expression of tenascin and fibronectin in nasal polyps.

Authors:  Zheng Liu; Qixue Gao; Song Zhang; Xuejun You; Yonghua Cui
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2002

Review 8.  Neutrophil elastase inhibitors.

Authors:  William C Groutas; Dengfeng Dou; Kevin R Alliston
Journal:  Expert Opin Ther Pat       Date:  2011-01-16       Impact factor: 6.674

9.  Inactivation of human neutrophil elastase by 1,2,5-thiadiazolidin-3-one 1,1 dioxide-based sulfonamides.

Authors:  Yi Li; Qingliang Yang; Dengfeng Dou; Kevin R Alliston; William C Groutas
Journal:  Bioorg Med Chem       Date:  2007-10-18       Impact factor: 3.641

10.  Characterisation of the proximal airway squamous metaplasia induced by chronic tobacco smoke exposure in spontaneously hypertensive rats.

Authors:  Sarah J Bolton; Kate Pinnion; Victor Oreffo; Martyn Foster; Kent E Pinkerton
Journal:  Respir Res       Date:  2009-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.